CLSDQ
Clearside Biomedical, Inc.
$0.2850
0.00%
No data for this timeframe.
Vol
Inst. Holders13 funds
Inst. Value$1.3M
Analyst Ratings
0Strong Buy
0Buy
5Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 18, 2025 | Needham | REITERATE | Hold → Hold |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $881.2K | — |
| BlackRock, Inc. | $165.5K | — |
| RENAISSANCE TECHNOLOGIES LLC | $100.2K | — |
| STATE STREET CORP | $65.1K | — |
| UBS Group AG | $36.9K | — |
13 institutional holders with $1.3M total value (323,145 shares) as of 2025-Q3. Top holders: VANGUARD, BlackRock,, RENAISSANCE.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 221,968 | $881.2K | 68.7% | — |
| 2 | BlackRock, Inc. | 41,677 | $165.5K | 12.9% | — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 25,247 | $100.2K | 7.8% | — |
| 4 | STATE STREET CORP | 16,387 | $65.1K | 5.1% | — |
| 5 | UBS Group AG | 9,303 | $36.9K | 2.9% | — |
| 6 | PNC FINANCIAL SERVICES GROUP, INC. | 7,194 | $28.6K | 2.2% | — |
| 7 | MORGAN STANLEY | 750 | $3.0K | 0.2% | — |
| 8 | WELLS FARGO & COMPANY/MN | 400 | $1.6K | 0.1% | — |
| 9 | BANK OF AMERICA CORP /DE/ | 118 | $469.00 | 0.0% | — |
| 10 | FMR LLC | 83 | $330.00 | 0.0% | — |
| 11 | BARCLAYS PLC | 14 | $56.00 | 0.0% | — |
| 12 | Allworth Financial LP | 3 | $12.00 | 0.0% | — |
| 13 | CITIGROUP INC | 1 | $4.00 | 0.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Nov 2025): 0% buy across 8 analysts — 0 strong buy, 0 buy, 5 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 18, 2025 | Needham | REITERATE | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 5 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 5 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 5 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 5 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 6 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 6 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.